Cogstate's June Quarter Net Sales Contracts Rises

MT Newswires Live

Jul 08

Cogstate (ASX:CGS) said it executed total net sales contracts worth $21.9 million in the June quarter, up from $14 million in the prior corresponding period, according to a Wednesday filing with the Australian bourse.

The company reported $89 million in net sales contracts in fiscal year 2026, representing a 116% increase from $41.3 million in fiscal year 2025, per the filing.

The company enters fiscal year 2027 with $118.5 million in contracted future revenue, reflecting 32% year-on-year growth, with $48.3 million expected to be recognized in the said fiscal year, the filing said.

Clinical trials revenue commitments for fiscal year 2027 rose 58% to $46.1 million, while healthcare revenue remained steady at $2.3 million, the filing added.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2649995533"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2649995533\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2649995533?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-08 07:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2649995533","market":"sg","top_or_hot":-1,"title":"Cogstate's June Quarter Net Sales Contracts Rises","media":"MT Newswires Live","content":"<html><body><p> Cogstate (ASX:CGS) said it executed total net sales contracts worth $21.9 million in the June quarter, up from $14 million in the prior corresponding period, according to a Wednesday filing with the Australian bourse.</p><p>The company reported $89 million in net sales contracts in fiscal year 2026, representing a 116% increase from $41.3 million in fiscal year 2025, per the filing.</p><p>The company enters fiscal year 2027 with $118.5 million in contracted future revenue, reflecting 32% year-on-year growth, with $48.3 million expected to be recognized in the said fiscal year, the filing said.</p><p>Clinical trials revenue commitments for fiscal year 2027 rose 58% to $46.1 million, while healthcare revenue remained steady at $2.3 million, the filing added.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cogstate's June Quarter Net Sales Contracts Rises</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCogstate's June Quarter Net Sales Contracts Rises\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-07-08 07:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Cogstate (ASX:CGS) said it executed total net sales contracts worth $21.9 million in the June quarter, up from $14 million in the prior corresponding period, according to a Wednesday filing with the Australian bourse.</p><p>The company reported $89 million in net sales contracts in fiscal year 2026, representing a 116% increase from $41.3 million in fiscal year 2025, per the filing.</p><p>The company enters fiscal year 2027 with $118.5 million in contracted future revenue, reflecting 32% year-on-year growth, with $48.3 million expected to be recognized in the said fiscal year, the filing said.</p><p>Clinical trials revenue commitments for fiscal year 2027 rose 58% to $46.1 million, while healthcare revenue remained steady at $2.3 million, the filing added.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CGS.AU","symbol_name":"COGSTATE LTD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2649995533","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2649995533","pubTimestamp":1783468104,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Cogstate  said it executed total net sales contracts worth $21.9 million in the June quarter, up from $14 million in the prior corresponding period, according to a Wednesday filing with the Australian bourse.The company reported $89 million in net sales contracts in fiscal year 2026, representing a 116% increase from $41.3 million in fiscal year 2025, per the filing.The company enters fiscal year 2027 with $118.5 million in contracted future revenue, reflecting 32% year-on-year growth, with $48.3 million expected to be recognized in the said fiscal year, the filing said.Clinical trials revenue commitments for fiscal year 2027 rose 58% to $46.1 million, while healthcare revenue remained steady at $2.3 million, the filing added.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CGS.AU":"COGSTATE LTD","BK7094":"医疗保健技术"},"translate_title":"Cogstate六月季度净销售合同上升","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CGS.AU":1},"content_text":"Cogstate (ASX:CGS) said it executed total net sales contracts worth $21.9 million in the June quarter, up from $14 million in the prior corresponding period, according to a Wednesday filing with the Australian bourse.The company reported $89 million in net sales contracts in fiscal year 2026, representing a 116% increase from $41.3 million in fiscal year 2025, per the filing.The company enters fiscal year 2027 with $118.5 million in contracted future revenue, reflecting 32% year-on-year growth, with $48.3 million expected to be recognized in the said fiscal year, the filing said.Clinical trials revenue commitments for fiscal year 2027 rose 58% to $46.1 million, while healthcare revenue remained steady at $2.3 million, the filing added.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}